345 related articles for article (PubMed ID: 38004570)
1. Treatment of Dry Eye Disease (DED) in Asia: Strategies for Short Tear Film Breakup Time-Type DED.
Kawahara A
Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004570
[TBL] [Abstract][Full Text] [Related]
2. Management Strategies for Evaporative Dry Eye Disease and Future Perspective.
Rolando M; Merayo-Lloves J
Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685
[TBL] [Abstract][Full Text] [Related]
3. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial.
Craig JP; Muntz A; Wang MTM; Luensmann D; Tan J; Trave Huarte S; Xue AL; Jones L; Willcox MDP; Wolffsohn JS
Ocul Surf; 2021 Apr; 20():62-69. PubMed ID: 33401019
[TBL] [Abstract][Full Text] [Related]
4. Topical corticosteroids for dry eye.
Liu SH; Saldanha IJ; Abraham AG; Rittiphairoj T; Hauswirth S; Gregory D; Ifantides C; Li T
Cochrane Database Syst Rev; 2022 Oct; 10(10):CD015070. PubMed ID: 36269562
[TBL] [Abstract][Full Text] [Related]
5. Safe and Effective Management of Dry Eye Symptoms with Hydroxypropyl Guar and Hyaluronic Acid Dual-Polymer Lubricating Eye Drops: A Review of Preclinical and Clinical Studies.
Srinivasan S; Garofalo R; Williams R
Clin Ophthalmol; 2023; 17():3883-3898. PubMed ID: 38105908
[TBL] [Abstract][Full Text] [Related]
6. Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study.
Zhang Q; Zhang H; Qin G; Wu Y; Song Y; Yang L; Yu S; He X; Moore JE; Moutari S; Palme C; Xu L; He W; Pazo EE
J Ocul Pharmacol Ther; 2022 Mar; 38(2):133-140. PubMed ID: 35049373
[No Abstract] [Full Text] [Related]
7. TFOS DEWS II Tear Film Report.
Willcox MDP; Argüeso P; Georgiev GA; Holopainen JM; Laurie GW; Millar TJ; Papas EB; Rolland JP; Schmidt TA; Stahl U; Suarez T; Subbaraman LN; Uçakhan OÖ; Jones L
Ocul Surf; 2017 Jul; 15(3):366-403. PubMed ID: 28736338
[TBL] [Abstract][Full Text] [Related]
8. Rethinking dry eye disease: a perspective on clinical implications.
Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials.
Liu S; Yang G; Li Q; Tang S
Indian J Ophthalmol; 2023 Apr; 71(4):1304-1315. PubMed ID: 37026262
[TBL] [Abstract][Full Text] [Related]
10. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
Sheppard J; Shen Lee B; Periman LM
Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
[TBL] [Abstract][Full Text] [Related]
11. Personalized Management of Dry Eye Disease: Beyond Artificial Tears.
Matossian C; Crowley M; Periman L; Sorkin S
Clin Ophthalmol; 2022; 16():3911-3918. PubMed ID: 36452043
[TBL] [Abstract][Full Text] [Related]
12. Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.
Gulati S; Jain S
Handb Exp Pharmacol; 2017; 242():97-118. PubMed ID: 27913889
[TBL] [Abstract][Full Text] [Related]
13. Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study.
Fukuoka S; Arita R
Sci Rep; 2019 Jun; 9(1):9091. PubMed ID: 31235821
[TBL] [Abstract][Full Text] [Related]
14. Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease.
Steven P; Augustin AJ; Geerling G; Kaercher T; Kretz F; Kunert K; Menzel-Severing J; Schrage N; Schrems W; Krösser S; Beckert M; Messmer EM
J Ocul Pharmacol Ther; 2017 Nov; 33(9):678-685. PubMed ID: 28922088
[TBL] [Abstract][Full Text] [Related]
15. Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease.
Srinivasan S; Williams R
Clin Ophthalmol; 2022; 16():3311-3326. PubMed ID: 36237486
[TBL] [Abstract][Full Text] [Related]
16. Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape.
Sheppard JD; Nichols KK
Ophthalmol Ther; 2023 Jun; 12(3):1397-1418. PubMed ID: 36856980
[TBL] [Abstract][Full Text] [Related]
17. The Importance of Preventing and Managing Tear Dysfunction Syndrome in Allergic Conjunctivitis and How to Tackle This Problem.
Montero-Iruzubieta J; Sanchez Hernandez MC; Dávila I; Leceta A
J Investig Allergol Clin Immunol; 2023 Dec; 33(6):439-445. PubMed ID: 38095493
[TBL] [Abstract][Full Text] [Related]
18. Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease.
Daull P; Amrane M; Ismail D; Georgiev G; Cwiklik L; Baudouin C; Leonardi A; Garhofer G; Garrigue JS
J Ocul Pharmacol Ther; 2020; 36(6):355-365. PubMed ID: 32493105
[TBL] [Abstract][Full Text] [Related]
19. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
